These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30763282)

  • 1. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis.
    Geng Y; Liu X; Liang J; Habiel DM; Kulur V; Coelho AL; Deng N; Xie T; Wang Y; Liu N; Huang G; Kurkciyan A; Liu Z; Tang J; Hogaboam CM; Jiang D; Noble PW
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30763282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2 drives lung fibrosis by activating a metastatic cancer signature in invasive lung fibroblasts.
    Liu X; Geng Y; Liang J; Coelho AL; Yao C; Deng N; Wang Y; Dai K; Huang G; Xie T; Liu N; Rowan SC; Taghavifar F; Kulur V; Liu Z; Stripp BR; Hogaboam CM; Jiang D; Noble PW
    J Exp Med; 2022 Oct; 219(10):. PubMed ID: 35980387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Surface Programmed Death Ligand-1 Expression Identifies a Sub-Population of Distal Epithelial Cells Enriched in Idiopathic Pulmonary Fibrosis.
    Ahmadvand N; Carraro G; Jones MR; Shalashova I; Noori A; Wilhelm J; Baal N; Khosravi F; Chen C; Zhang JS; Ruppert C; Guenther A; Wasnick RM; Bellusci S
    Cells; 2022 May; 11(10):. PubMed ID: 35626630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.
    Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J
    Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.
    Habiel DM; Espindola MS; Coelho AL; Hogaboam CM
    Am J Pathol; 2018 Apr; 188(4):891-903. PubMed ID: 29378172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis.
    Karampitsakos T; Galaris A; Chrysikos S; Papaioannou O; Vamvakaris I; Barbayianni I; Kanellopoulou P; Grammenoudi S; Anagnostopoulos N; Stratakos G; Katsaras M; Sampsonas F; Dimakou K; Manali ED; Papiris S; Tourki B; Juan-Guardela BM; Bakakos P; Bouros D; Herazo-Maya JD; Aidinis V; Tzouvelekis A
    Respir Res; 2023 Nov; 24(1):279. PubMed ID: 37964265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts.
    Cai GQ; Zheng A; Tang Q; White ES; Chou CF; Gladson CL; Olman MA; Ding Q
    Exp Cell Res; 2010 May; 316(9):1600-9. PubMed ID: 20109444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.
    Lovgren AK; Kovacs JJ; Xie T; Potts EN; Li Y; Foster WM; Liang J; Meltzer EB; Jiang D; Lefkowitz RJ; Noble PW
    Sci Transl Med; 2011 Mar; 3(74):74ra23. PubMed ID: 21411739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periostin plays a critical role in the cell cycle in lung fibroblasts.
    Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
    Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
    Jones IC; Espindola MS; Narayanan R; Coelho AL; Habiel DM; Boehme SA; Ly TW; Bacon KB; Hogaboam CM
    Sci Rep; 2019 Dec; 9(1):19796. PubMed ID: 31875033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44.
    Li Y; Jiang D; Liang J; Meltzer EB; Gray A; Miura R; Wogensen L; Yamaguchi Y; Noble PW
    J Exp Med; 2011 Jul; 208(7):1459-71. PubMed ID: 21708929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance.
    Yang L; Xia H; Gilbertsen A; Smith K; Racila E; Bitterman PB; Henke CA
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L849-L862. PubMed ID: 37121574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
    Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
    JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.
    Hohmann MS; Habiel DM; Espindola MS; Huang G; Jones I; Narayanan R; Coelho AL; Oldham JM; Noth I; Ma SF; Kurkciyan A; McQualter JL; Carraro G; Stripp B; Chen P; Jiang D; Noble PW; Parks W; Woronicz J; Yarranton G; Murray LA; Hogaboam CM
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33945505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
    Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invadosome Formation by Lung Fibroblasts in Idiopathic Pulmonary Fibrosis.
    Lebel M; Cliche DO; Charbonneau M; Adam D; Brochiero E; Dubois CM; Cantin AM
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.